Pharmacokinetic Comparison of Isoalantolactone and Alantolactone in Rats after Administration Separately by Optimization of an UPLC-MS2 Method

Isoalantolactone and alantolactone are two major active ingredients that are present in many medicinal plants. In this study, a sensitive and rapid ultraperformance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method was developed for determination of the two compounds in rat plasma,...

Full description

Saved in:
Bibliographic Details
Main Authors: Renjie Xu, Mengyue Wang, Ying Peng, Xiaobo Li
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Journal of Chemistry
Online Access:http://dx.doi.org/10.1155/2014/354618
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832559041437499392
author Renjie Xu
Mengyue Wang
Ying Peng
Xiaobo Li
author_facet Renjie Xu
Mengyue Wang
Ying Peng
Xiaobo Li
author_sort Renjie Xu
collection DOAJ
description Isoalantolactone and alantolactone are two major active ingredients that are present in many medicinal plants. In this study, a sensitive and rapid ultraperformance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method was developed for determination of the two compounds in rat plasma, separately. In this method, an electrospray ionization source was applied and operated in positive ion mode; multiple reaction monitoring (MRM) was selected for quantification using target fragment ions 233.2→187.1 for isoalantolactone (alantolactone) and 245.1→189.1 for internal standard (IS). Retention time of the lactones and IS was within 3.0 min. Further calibration suggested a linear regression can be calculated within 2.5–500 ng/mL for isoalantolactone and 4–500 ng/mL for alantolactone. This method was used to compare the pharmacokinetic characteristics of isoalantolactone and alantolactone at a single dose of 5 mg/kg into male Sprague-Dawley rats by intravenous administration separately. The levels of t1/2, Kel, CL, Cmax, and AUC were significantly increased in the alantolactone group compared to isoalantolactone. These results suggested that isoalantolactone was distributed and eliminated more rapidly than alantolactone in rats when administered, respectively.
format Article
id doaj-art-f275884c46744ca8bde6b49b8b38197e
institution Kabale University
issn 2090-9063
2090-9071
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Journal of Chemistry
spelling doaj-art-f275884c46744ca8bde6b49b8b38197e2025-02-03T01:31:04ZengWileyJournal of Chemistry2090-90632090-90712014-01-01201410.1155/2014/354618354618Pharmacokinetic Comparison of Isoalantolactone and Alantolactone in Rats after Administration Separately by Optimization of an UPLC-MS2 MethodRenjie Xu0Mengyue Wang1Ying Peng2Xiaobo Li3School of Pharmacy, Shanghai Jiao Tong University, No. 800 Dongchuan Road, Minhang District, Shanghai 200240, ChinaSchool of Pharmacy, Shanghai Jiao Tong University, No. 800 Dongchuan Road, Minhang District, Shanghai 200240, ChinaSchool of Pharmacy, Shanghai Jiao Tong University, No. 800 Dongchuan Road, Minhang District, Shanghai 200240, ChinaSchool of Pharmacy, Shanghai Jiao Tong University, No. 800 Dongchuan Road, Minhang District, Shanghai 200240, ChinaIsoalantolactone and alantolactone are two major active ingredients that are present in many medicinal plants. In this study, a sensitive and rapid ultraperformance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method was developed for determination of the two compounds in rat plasma, separately. In this method, an electrospray ionization source was applied and operated in positive ion mode; multiple reaction monitoring (MRM) was selected for quantification using target fragment ions 233.2→187.1 for isoalantolactone (alantolactone) and 245.1→189.1 for internal standard (IS). Retention time of the lactones and IS was within 3.0 min. Further calibration suggested a linear regression can be calculated within 2.5–500 ng/mL for isoalantolactone and 4–500 ng/mL for alantolactone. This method was used to compare the pharmacokinetic characteristics of isoalantolactone and alantolactone at a single dose of 5 mg/kg into male Sprague-Dawley rats by intravenous administration separately. The levels of t1/2, Kel, CL, Cmax, and AUC were significantly increased in the alantolactone group compared to isoalantolactone. These results suggested that isoalantolactone was distributed and eliminated more rapidly than alantolactone in rats when administered, respectively.http://dx.doi.org/10.1155/2014/354618
spellingShingle Renjie Xu
Mengyue Wang
Ying Peng
Xiaobo Li
Pharmacokinetic Comparison of Isoalantolactone and Alantolactone in Rats after Administration Separately by Optimization of an UPLC-MS2 Method
Journal of Chemistry
title Pharmacokinetic Comparison of Isoalantolactone and Alantolactone in Rats after Administration Separately by Optimization of an UPLC-MS2 Method
title_full Pharmacokinetic Comparison of Isoalantolactone and Alantolactone in Rats after Administration Separately by Optimization of an UPLC-MS2 Method
title_fullStr Pharmacokinetic Comparison of Isoalantolactone and Alantolactone in Rats after Administration Separately by Optimization of an UPLC-MS2 Method
title_full_unstemmed Pharmacokinetic Comparison of Isoalantolactone and Alantolactone in Rats after Administration Separately by Optimization of an UPLC-MS2 Method
title_short Pharmacokinetic Comparison of Isoalantolactone and Alantolactone in Rats after Administration Separately by Optimization of an UPLC-MS2 Method
title_sort pharmacokinetic comparison of isoalantolactone and alantolactone in rats after administration separately by optimization of an uplc ms2 method
url http://dx.doi.org/10.1155/2014/354618
work_keys_str_mv AT renjiexu pharmacokineticcomparisonofisoalantolactoneandalantolactoneinratsafteradministrationseparatelybyoptimizationofanuplcms2method
AT mengyuewang pharmacokineticcomparisonofisoalantolactoneandalantolactoneinratsafteradministrationseparatelybyoptimizationofanuplcms2method
AT yingpeng pharmacokineticcomparisonofisoalantolactoneandalantolactoneinratsafteradministrationseparatelybyoptimizationofanuplcms2method
AT xiaoboli pharmacokineticcomparisonofisoalantolactoneandalantolactoneinratsafteradministrationseparatelybyoptimizationofanuplcms2method